文献速递焦虑、强迫与应激相关障碍

创伤后应激障碍心理治疗更新

An Update on Psychotherapy for the Treatment of PTSD.
PubMed 文献 · Am J Psychiatry · 2025-01-01

综述指出大多数创伤幸存者会自然康复,但少数会发展为慢性PTSD。目前仅舍曲林和帕罗西汀获FDA批准治疗PTSD,且药物及药物联合心理治疗均非指南一线推荐;一线推荐仅为聚焦创伤的心理治疗,包括延长暴露、认知加工治疗等。致幻剂辅助心理治疗应答率较高,但未整合循证心理治疗。

要点

  • PTSD一线治疗为聚焦创伤的心理治疗,药物不作一线推荐。
  • VA/DoD指南推荐PE、CPT和EMDR;APA指南推荐PE、CPT、认知治疗和TF-CBT。
  • 致幻剂辅助心理治疗应答率较高,但未结合循证PTSD心理治疗。

核心结论

  • 聚焦创伤的心理治疗是PTSD唯一一线推荐干预,药物及联合治疗均非一线。

研究设计与样本

  • 本文为综述,简要回顾当前PTSD心理治疗及其对临床和神经生物学指标的影响。

主要发现

  • 大多数创伤幸存者不经干预可康复,但少数会发展为慢性PTSD且不经干预难以缓解。
  • 仅舍曲林和帕罗西汀获FDA批准治疗PTSD,布瑞哌唑联合舍曲林及MDMA辅助治疗正在审评。
  • 致幻剂辅助心理治疗未纳入循证PTSD心理治疗,但应答率高于其他联合治疗试验。

关键数值与推荐

  • VA/DoD PTSD指南推荐PE、CPT和EMDR为一线治疗。
  • APA PTSD指南推荐PE、CPT、认知治疗和聚焦创伤的认知行为治疗为一线治疗。

临床怎么用

  • 临床应优先选用聚焦创伤的心理治疗作为PTSD一线干预。
  • 药物及药物联合心理治疗不作为一线推荐,需根据指南权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Posttraumatic stress disorder (PTSD) symptoms are part of the normal response to trauma. Most trauma survivors will recover over time without intervention, but a significant minority will develop chronic PTSD, which is unlikely to remit without intervention. Currently, only two medications, sertraline and paroxetine, are approved by the U.S. Food and Drug Administration to treat PTSD, and the combination of brexpiprazole and sertraline and MDMA-assisted therapy have FDA applications pending. These medications, and the combination of pharmacotherapy and psychotherapy, are not recommended as first-line treatments in any published PTSD treatment guidelines. The only interventions recommended as first-line treatments are trauma-focused psychotherapies; the U.S. Department of Veterans Affairs/Department of Defense PTSD treatment guideline recommends prolonged exposure (PE), cognitive processing therapy (CPT), and eye movement desensitization and reprocessing, and the American Psychological Association PTSD treatment guideline recommends PE, CPT, cognitive therapy, and trauma-focused cognitive-behavioral therapy. Although published clinical trials of psychedelic-assisted psychotherapy have not incorporated evidence-based PTSD psychotherapies, they have achieved greater response rates than other trials of combination treatment, and there is some enthusiasm about combining psychedelic medications with evidence-based psychotherapies. The state-of-the-art PTSD psychotherapies are briefly reviewed here, including their effects on clinical and neurobiological measures.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Rothbaum BO, Watkins LE. An Update on Psychotherapy for the Treatment of PTSD. Am J Psychiatry. 2025. PMID: 40308104. doi:10.1176/appi.ajp.20250110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。